Imjudo 25 mg/1

Imjudo 25 mg/1 is a medicine authorised by Swissmedic under authorisation number 68706. The authorisation holder is AstraZeneca AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 September 2023 and the authorisation is limited until 12 September 2028. ATC code L01FX20 places the medicine in the group Antineoplastic agents.

Dispensing category A
Authorisation number 68706
ATC L01FX20
Biotechnological medicines

Authorisation data
Authorisation number	68706
Name	Imjudo 25 mg/1
Full name	Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holder	AstraZeneca AG
Medicinal product code	Biotechnological medicines
Dispensing category	A · Prescription, not repeatable
ATC code	L01FX20
First authorisation	13 September 2023
Authorisation validity	12 September 2028

Strengths
No.	Name	Dispensing category	Authorisation date
1	Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung	A	13 September 2023
2	Imjudo 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung	A	13 September 2023

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	1	Durchstechflasche(n)	L01FX20	07.16.1.	A
2	1	Durchstechflasche(n)	L01FX20	07.16.1.	A

Scroll the table sideways

Other medicines from this authorisation holder

AxultaAuthorisation number 65402 · ATC A06AX04B Bricanyl TurbuhalerAuthorisation number 48943 · ATC R03AC03B Brilique 90 mgAuthorisation number 61389 · ATC B01AC24B Brilique 90 mgAuthorisation number 66822 · ATC B01AC24B Calquence 100 mgAuthorisation number 68817 · ATC L01EL02A Daxas 500 ugAuthorisation number 60484 · ATC R03DX07B Fasenra 30 mg /1 mlAuthorisation number 66582 · ATC R03DX10B Fasenra Pen 30 mg /1 mlAuthorisation number 67581 · ATC R03DX10B

Frequently asked questions

Is Imjudo 25 mg/1 authorised in Switzerland?

Yes. Imjudo 25 mg/1 is authorised by Swissmedic under authorisation number 68706, data as of 01 September 2026. The authorisation is limited until 12 September 2028.

Which dispensing category does Imjudo 25 mg/1 have?

Imjudo 25 mg/1 is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Imjudo 25 mg/1?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.